Juvenile Macular Degeneration Market Leading Players Acucela Inc. (U.S.), Alkeus Pharmaceuticals Inc. (U.S.) Forecast 2023

12/gen/2021 07:15:20 Market Research Future Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Juvenile Macular Degeneration Market China and India contribute to the growth of the market. On the other hand, the Middle East & Africa hold the least share of the market due to the low prevalence of macular degeneration in the region and limited availability of funds and availability of medical facilities. The Middle East has a huge share for the Juvenile Macular Degeneration Market due to the presence of well-developed countries like Kuwait, Qatar, Oman and Saudi Arabia. However, due to the presence of a huge opportunity for the development of the market, Africa region is expecting a healthy growth in near future. Global Juvenile Macular Degeneration (Stargardt Disease) market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.

Sample Report: https://www.marketresearchfuture.com/sample_request/4935

Key Players in Global Juvenile Macular Degeneration Market Acucela Inc. (U.S.), Alkeus Pharmaceuticals Inc. (U.S.), Astellas Pharma Inc. (Japan), ProQR Therapeutics NV (Netherland), Sanofi (France), Bayer HealthCare (Germany), F. Hoffmann-La Roche (Switzerland), Copernicus Therapeutics Inc. (U.S.), Grupo Ferrer Internacional SA (U.S.), Iris Pharma (U.S.), Nemus Bioscience Inc (U.S.), Ophthotech Corp (U.S.), Iconic Therapeutics (U.S.), Adverum Biotechnologies (U.S.), PanOptica (U.S.), RXi Pharmaceuticals (U.S.), Neurotech Pharmaceuticals (U.S.)

The European juvenile macular degeneration market accounted for 32.7% market share in 2016. In Europe, Germany, the U.K, and France are the largest contributors to the market owing to the availability of funds for research, and extensive research and development activities in ophthalmology. The development of novel therapies and other treatment options for juvenile macular degeneration also fuel the growth of the market. The Middle East & Africa exhibit steady but positive growth owing to low technology penetration in developing regions of Africa, and increasing demand for diagnostics services in developing regions. In the Middle East, the United Arab Emirates accounts for the largest market share for macular degeneration.

READ MORE @ https://www.marketresearchfuture.com/reports/juvenile-macular-degeneration-market-4935

About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl